On a consolidated basis, Ipca Laboratories recorded 94% jump in net profit to Rs 161.20 crore in Q4 FY21 as against Rs 83.05 crore in Q4 FY20.
Revenue from operations rose 3.81% year-on-year (YoY) to Rs 1,114.66 crore during the quarter.
The company incurred a forex gain of Rs 13.24 crore in the fourth quarter compared with a forex loss of Rs 23.62 crore in the same period last year.
Profit before tax in Q4 FY21 stood at Rs 192.13 crore, up by 71.2% from Rs 112.25 crore in Q4 FY20.
The company recorded 89% rise in consolidated net profit to Rs 1141 crore on 16.6% increase in revenue from operations to Rs 5,419.99 crore in FY21 over FY20.
Ipca is a pharmaceutical company with a strong thrust on exports which now account for 52% of company's income. Ipca is vertically integrated and produces finished dosage forms and active pharmaceutical ingredients.
The scrip slumped 7.98% to end at Rs 2024.25 on Friday.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app